Hillsdale Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $224K | Sell |
1,861
-27,270
| -94% | -$3.15M | 0.01% | 554 |
|
|
2025
Q4 | $3.07M | Sell |
29,131
-29,260
| -50% | -$2.75M | 0.08% | 293 |
|
|
2025
Q3 | $4.9M | Sell |
58,391
-10,630
| -15% | -$876K | 0.15% | 199 |
|
|
2025
Q2 | $5.46M | Buy |
69,021
+50,530
| +273% | +$4.02M | 0.2% | 142 |
|
|
2025
Q1 | $1.66M | Buy |
18,491
+800
| +5% | +$74.7K | 0.08% | 212 |
|
|
2024
Q4 | $1.76M | Buy |
17,691
+5,480
| +45% | +$565K | 0.09% | 214 |
|
|
2024
Q3 | $1.39M | Buy |
12,211
+7,564
| +163% | +$899K | 0.11% | 214 |
|
|
2024
Q2 | $575K | Buy |
4,647
+3,240
| +230% | +$417K | 0.05% | 301 |
|
|
2024
Q1 | $186K | Sell |
1,407
-400
| -22% | -$49.3K | 0.01% | 378 |
|
|
2023
Q4 | $197K | Sell |
1,807
-700
| -28% | -$72.7K | 0.02% | 359 |
|
|
2023
Q3 | $258K | Buy |
2,507
+1,000
| +66% | +$108K | 0.02% | 338 |
|
|
2023
Q2 | $174K | Sell |
1,507
-900
| -37% | -$102K | 0.02% | 328 |
|
|
2023
Q1 | $256K | Sell |
2,407
-4,840
| -67% | -$523K | 0.02% | 407 |
|
|
2022
Q4 | $804K | Sell |
7,247
-2,520
| -26% | -$258K | 0.07% | 199 |
|
|
2022
Q3 | $842K | Buy |
9,767
+811
| +9% | +$72.4K | 0.08% | 185 |
|
|
2022
Q2 | $816K | Sell |
8,956
-118
| -1% | -$10.5K | 0.07% | 209 |
|
|
2022
Q1 | $744K | Buy |
9,074
+7,920
| +686% | +$624K | 0.05% | 294 |
|
|
2021
Q4 | $88K | Buy |
+1,154
| New | +$91.9K | 0.01% | 446 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$39K | – | 610 |
|
|
2021
Q2 | $39K | Sell |
500
-600
| -55% | -$44.6K | ﹤0.01% | 493 |
|
|
2021
Q1 | $81K | Sell |
1,100
-126
| -10% | -$9.29K | 0.01% | 429 |
|
|
2020
Q4 | $96K | Sell |
1,226
-5,617
| -82% | -$430K | 0.01% | 414 |
|
|
2020
Q3 | $541K | Sell |
6,843
-126
| -2% | -$9.87K | 0.05% | 300 |
|
|
2020
Q2 | $514K | Sell |
6,969
-2,002
| -22% | -$151K | 0.05% | 313 |
|
|
2020
Q1 | $658K | Buy |
8,971
+84
| +0.9% | +$6.6K | 0.08% | 229 |
|
|
2019
Q4 | $771K | Buy |
8,887
+597
| +7% | +$49K | 0.07% | 275 |
|
|
2019
Q3 | $667K | Buy |
8,290
+388
| +5% | +$31.1K | 0.06% | 282 |
|
|
2019
Q2 | $633K | Sell |
7,902
-31
| -0.4% | -$2.37K | 0.06% | 282 |
|
|
2019
Q1 | $629K | Buy |
7,933
+1,027
| +15% | +$76.8K | 0.06% | 208 |
|
|
2018
Q4 | $504K | Buy |
6,906
+5,753
| +499% | +$406K | 0.06% | 194 |
|
|
2018
Q3 | $78K | Sell |
1,153
-5,240
| -82% | -$334K | 0.01% | 273 |
|
|
2018
Q2 | $370K | Buy |
+6,393
| New | +$361K | 0.05% | 258 |
|
|
2017
Q4 | – | Sell |
-6,078
| Closed | -$371K | – | 515 |
|
|
2017
Q3 | $371K | Buy |
+6,078
| New | +$368K | 0.06% | 239 |
|
|
2017
Q1 | – | Sell |
-755
| Closed | -$42K | – | 516 |
|
|
2016
Q4 | $42K | Sell |
755
-188
| -20% | -$11K | 0.01% | 314 |
|
|
2016
Q3 | $56K | Sell |
943
-629
| -40% | -$36.8K | 0.01% | 329 |
|
|
2016
Q2 | $86K | Hold |
1,572
| – | – | 0.03% | 323 |
|
|
2016
Q1 | $79K | Hold |
1,572
| – | – | 0.03% | 320 |
|
|
2015
Q4 | $79K | Sell |
1,572
-2,096
| -57% | -$106K | 0.03% | 318 |
|
|
2015
Q3 | $173K | Sell |
3,668
-419
| -10% | -$22.3K | 0.06% | 337 |
|
|
2015
Q2 | $222K | Buy |
4,087
+105
| +3% | +$5.89K | 0.07% | 335 |
|
|
2015
Q1 | $218K | Buy |
3,982
+524
| +15% | +$29.7K | 0.06% | 335 |
|
|
2014
Q4 | $187K | Hold |
3,458
| – | – | 0.05% | 334 |
|
|
2014
Q3 | $196K | Sell |
3,458
-420
| -11% | -$23.6K | 0.06% | 309 |
|
|
2014
Q2 | $214K | Sell |
3,878
-1,152
| -23% | -$62.8K | 0.05% | 315 |
|
|
2014
Q1 | $272K | Sell |
5,030
-420
| -8% | -$21.7K | 0.08% | 224 |
|
|
2013
Q4 | $260K | Buy |
5,450
+1,363
| +33% | +$62.3K | 0.08% | 253 |
|
|
2013
Q3 | $186K | Buy |
4,087
+314
| +8% | +$14.3K | 0.06% | 293 |
|
|
2013
Q2 | $167K | Buy |
+3,773
| New | +$169K | 0.05% | 323 |
|
Other funds holding MRK
VCM
VPM
Hillsdale Investment Management's MRK Position: Q1 2026 in Review
Hillsdale Investment Management reduced its Merck (MRK) stake by 94% in Q1 2026, selling an estimated $3.15M and leaving 1,861 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #554.
Hillsdale Investment Management first reported a position in MRK in Q2 2013 and has held it in 47 quarters since. The position peaked at $5.46M in Q2 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Hillsdale Investment Management held 1,861 shares of Merck worth $224K as of Q1 2026.
- Hillsdale Investment Management sold 27,270 Merck shares in Q1 2026, an estimated $3.15M.
- Merck made up 0.01% of Hillsdale Investment Management's portfolio in Q1 2026, its #554 holding.
- Hillsdale Investment Management first reported a position in Merck in Q2 2013 and has held it in 47 quarters since.
- Hillsdale Investment Management's Merck position peaked at $5.46M in Q2 2025.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.